September 27, 2022

Volume XII, Number 270

Advertisement

September 26, 2022

Subscribe to Latest Legal News and Analysis
Advertisement

Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act – Diagnosing Health Care [Podcast]

In this episode of the Diagnosing Health Care Podcast:  For years, pharmacy advocates have urged policymakers to make changes to state scope of practice laws that would permit pharmacists to prescribe and administer certain tests and vaccines at the pharmacy. How has COVID-19 impacted these efforts?

Hear from special guest Will Chang, Chief Legal Officer of UpStream.

Will and Epstein Becker Green attorneys Richard Hughes and Kala Shankle discuss the history of pharmacists’ scope of practice before the pandemic and how COVID-19 response efforts used a declaration under the Public Readiness and Emergency Preparedness Act to release pharmacists as testers and vaccinators for the country. The group also discusses what’s next for scope of practice rules as the pandemic emergency winds down.

©2022 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XII, Number 223
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Richard Hughes Health Insurance Lawyer Epstein Becker Washington DC
Member

Richard Hughes leverages his background as a health insurance lawyer and health care policy executive to help pharmaceutical, biotechnology, and health care entities navigate a broad range of legal, regulatory, and policy issues.

As a vaccine thought leader, Richard has led many efforts to expand access to vaccines and preventive services that improve public health outcomes. His thought leadership and problem-solving strategies have broken barriers to access to vaccines and PrEP for HIV, and his advice on vaccine policy is sought after by leading manufacturers, members of Congress,...

202-861-1893
Healthcare Attorney Kala Shankle of Epstein Becker Washington DC
Associate

Attorney Kala Shankle deftly navigates clients through pharmacy laws and drug pricing, reimbursement, and supply chain issues. Her legal counsel is guided by a deep understanding of a client’s business and objectives, coupled with the dynamics of federal and state regulatory landscapes.

For retail and specialty pharmacies, pharmacy benefit managers, insurers, and other health care providers and suppliers, Kala counsels on drug reimbursement by private insurers and government programs, 340B drug program compliance and management, supply chain laws and regulations, and provider...

202-861-1866
Advertisement
Advertisement
Advertisement